story of the week
Association Between SGLT2 Inhibitor Use and a Reduced Risk for New-Onset Type 2 Diabetes in Adults With Prediabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Clinical Endocrinology and Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials
J. Clin. Endocrinol. Metab. 2022 Oct 11;[EPub Ahead of Print], Y Mori, OK Duru, KR Tuttle, S Fukuma, D Taura, N Harada, N Inagaki, K InoueFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.